London, UK (CU)_ A conditional marketing approval for Xevudy (sotrovimab) has been given to GlaxoSmithKline (GSK) and Vir Biotechnology by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of acute…
GSK and Vir Biotechnology’s Xevudy Receives MHRA Conditional Marketing Authorization
-
